Is Cyclerion Therapeutics Inc (CYCN) undervalued? · rev $2.0M
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
This page asks whether Cyclerion Therapeutics Inc (CYCN) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported CYCN revenue for 2024-12-31 was $2.0M. Net income was -$3.1M. CYCN currently screens at market cap $8.6M.
CYCN currently screens at market cap $8.6M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new CYCN 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare CYCN to the stock page model before you treat a low multiple as a gift.
Not investment advice.